Epidemiology, clinical and laboratory characteristics of currently alive HIV-1 infected former blood donors naive to antiretroviral therapy in Anhui Province, China

Chinese Medical Journal

Volumn 119, Issue 23, 2006, Pages 1941-1948

  Xu, Jian Qing ^a   Wang, Jian Jun ^b   Han, Li Feng ^a   Xu, Chen ^c   Ruan, Yu Hua ^a   Xu, Zhen Hou ^d   Chen, Xi ^a   Liu, Zhen Dong ^e   Wang, Jun ^a   Su, Bing ^b   Ding, Xin Ping ^c   Gao, Bing ^d   Gu, Yong Bin ^e   Cao, Xiao Yun ^a   Xing, Hui ^a   Hong, Kun Xue ^a   Peng, Hong ^a   Zhao, Quan Bi ^a   Yuan, Lin ^a   Feng, Yi ^a   Zhang, Gui Yun ^a   Ma, Li Ying ^a   Wu, Lan ^a   Shao, Yi Ming ^a   more..

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Anhui Center for Control and Prevention of Animal Infectious Disease   (China)

^c Fuyang City Center for Disease Control   (China)

^d Yingzhou Center for Disease Control and Prevention   (China)

^e Funan Center for Disease Control and Prevention   (China)

Author keywords

Blood donors; Co infection; Disease progression; Hepatitis C; Human immunodeficiency virus

Indexed keywords

ANTIRETROVIRUS AGENT; HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD DONOR; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHINA; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LABORATORY TEST; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; PREVALENCE; SKIN DISEASE; VIRUS LOAD; VIRUS TRANSMISSION; CROSS-SECTIONAL STUDY; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; BLOOD DONORS; CHINA; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED;

EID: 33847095142     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200612010-00002     Document Type: Article

References (23)

1. Anonymous. Newly released information on AIDS control and prevention by deputy minister Longde Wang at Ministry of Health. AIDS 2005; 8: 1-3.
2. Kaufman J, Jing J. China and AIDS - the time to act is now. Science 2002; 296: 2339-2340.
3. Shan H, Wang JX, Ren FR, Zhang YZ, Zhao HY, Cao GJ, et al. Blood banking in China. Lancet 2002; 360: 1770-1775.
4. Beach MV "Blood heads" and AIDS haunt China's countryside. Lancet 2001; 357: 49.
5. World Health Organization. Acquired immunodefiency syndrome (AIDS). Interim proposal for a WHO staging system for HIV infection and disease. Wkly Epidemiol Rec 1990; 65: 221-223.
6. Xia GL, Liu GB, Cao HL. Prevalence of hepatitis B and C virus infections in the general Chinese population: result from a nationwide cross-sectional sero-epideiologic study of hepatitis A, B, C, D and E virus infections in China. Int Hepatol Commun 1996; 5: 62-73.
7. Wu Z, Rou K, Detels R. Prevalence of HIV infection among former commercial plasma donors in rural eastern china. Health Policy Plan 2001; 16: 41-46.
8. Cheng H, Qian X, Cao GH, Chen CK, Cao YN, Jiang QW. Study on the seropositive prevalence of human immunodeficiency virus in a village residents living in rural region of central China. Chin J Epidemiol (Chin) 2004; 25: 317-321.
9. Wang L, Zheng XW, Qian HZ, Lu F, Xing H. Epidemiologic study on human-immunodeficiency virus infection among children in a former paid plasma donating community in China. Chin Med J 2005; 118: 720-724.
10. Garten RJ, Lai S, Zhang J, Liu W, Chen J, Vlahov D, et al. Rapid transmission of-hepatitis C virus among young injecting heroin users in Southern China. Int J Epidemiol 2004; 33: 182-188.
11. Zhang LQ, Chen ZW, Cao YZ, Yu J, Li GH, Yu WJ, et al. Molecular characterization of human immunodeficiency virus type I and hepatitis C virus in paid blood donor and injection drug users in China. J Virol 2004; 78: 13591-13599.
12. Fang JN, Jin CJ, Cui LH, Quan ZY, Choi BY, Ki M, et al. A comparative study on serologic profiles of virus hepatitis B. World J Gastroenterol 2001; 7: 107-110, 115.
13. Qu JB, Zhang ZW, Shimbo S, Watanabe T, Nakatsuka H, Matsuda-Inoguchi N, et al. Urban-rural comparison of HBV and HCV infection prevalence in eastern China. Biomed Environ Sci 2000; 13: 243-253.
14. Horvath J, Raffanti SP. Clinical aspects of the interaction between human immunodeficiency virus and the hepatotropic viruses. Clin infect Dis 1994; 18: 339-347.
15. Glison RJ. Hawkins AE, Beecham MR, Ross E, Waite J, Briggs M, et al. Interactions between HIV and hepatitis B Virus in homosexual men: effects on the natural history of infection. AIDS 1997; 11: 597-606.
16. Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Use of total lymphocyte count and hemoglobin concentration for monitoring progression of HIV infection. J Acquir Immune Defic Syndr 2005; 39: 620-625.
17. Anastos K, Shi Q, French AL, Levine A, Greenblatt RM, Williams C, et al. Total lymphocyte count, hemoglobin, and delayed-type hypersensitivity as predictors of death and AIDS illness in HIV-1-infected women receiving highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2004; 35: 383-392.
18. Lau B, Gange SJ, Phair JP, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte counts and hemoglobin concentration prior to AIDS among HIV-1-infected men. AIDS 2003; 17: 2035-2044.
19. + cell count falls below 200 cells/μl. Int J Epidemiol 1998; 27: 897-903.
20. Farzadegan H, Henrard DR, Kleeberger CA, Schrager L, Kirby AJ, Rinaldo CR Jr, et al. Virologic and serologic markers of rapid progression to AIDS after HIV-1 seroconversion. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 13: 448-455.
21. Mellors JW, Kingsley LA, Rinaldo CR Jr, Todd JA, Hoo BS, Kokka RP, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995; 122: 573-579.
22. Alter G, Teigen N, Davis BT, Addo MM, Suscovich TJ, Waring MT, et al. Sequential deregulation of NK cell subset distribution and function starting in acute HIV-1 infection. Blood 2005; 106: 3366-3369.
23. Kamga I, Kahi S, Develioglu L, Lichtner M, Maranon C, Deveau C, et al. Type I interferon production is profoundly and transiently impaired in primary HIV-1 infection. J Infect Dis 2005; 192: 303-310.